These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 21035400)

  • 21. Amyotrophic lateral sclerosis.
    Jackson CE; Bryan WW
    Semin Neurol; 1998; 18(1):27-39. PubMed ID: 9562665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
    Vucic S; Kiernan MC
    Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyotrophic lateral sclerosis.
    Hardiman O; Al-Chalabi A; Chio A; Corr EM; Logroscino G; Robberecht W; Shaw PJ; Simmons Z; van den Berg LH
    Nat Rev Dis Primers; 2017 Oct; 3():17071. PubMed ID: 28980624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis.
    D'Amico E; Grosso G; Nieves JW; Zanghì A; Factor-Litvak P; Mitsumoto H
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression.
    Ioannides ZA; Ngo ST; Henderson RD; McCombe PA; Steyn FJ
    Neurodegener Dis; 2016; 16(5-6):382-97. PubMed ID: 27400276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyotrophic lateral sclerosis: a hormonal condition?
    Blasco H; Guennoc AM; Veyrat-Durebex C; Gordon PH; Andres CR; Camu W; Corcia P
    Amyotroph Lateral Scler; 2012 Oct; 13(6):585-8. PubMed ID: 22873563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic.
    Mancuso R; Navarro X
    Prog Neurobiol; 2015 Oct; 133():1-26. PubMed ID: 26253783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermetabolism in ALS is associated with greater functional decline and shorter survival.
    Steyn FJ; Ioannides ZA; van Eijk RPA; Heggie S; Thorpe KA; Ceslis A; Heshmat S; Henders AK; Wray NR; van den Berg LH; Henderson RD; McCombe PA; Ngo ST
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1016-1023. PubMed ID: 29706605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amyotrophic lateral sclerosis. In search of its etio-pathogenic mechanisms].
    Bonduelle M
    Recenti Prog Med; 1989 Dec; 80(12):659-64. PubMed ID: 2697901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nutritional management in amyotrophic lateral sclerosis: A medical and ethical stake].
    Lehéricey G; Le Forestier N; Dupuis L; Gonzalez-Bermejo J; Meininger V; Pradat PF
    Presse Med; 2012 Jun; 41(6 Pt 1):560-74. PubMed ID: 22137288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical presentation and diagnosis of amyotrophic lateral sclerosis.
    Ferguson TA; Elman LB
    NeuroRehabilitation; 2007; 22(6):409-16. PubMed ID: 18198425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New therapy options for amyotrophic lateral sclerosis.
    Gordon P; Corcia P; Meininger V
    Expert Opin Pharmacother; 2013 Oct; 14(14):1907-17. PubMed ID: 23855817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
    J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.
    Krüger T; Lautenschläger J; Grosskreutz J; Rhode H
    Proteomics Clin Appl; 2013 Jan; 7(1-2):123-35. PubMed ID: 23129563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenesis and therapeutic perspectives for amyotrophic lateral sclerosis (ALS)].
    Abe K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):790-4. PubMed ID: 18210800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
    Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
    Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis.
    Zhou J; Yi J; Bonewald L
    Curr Osteoporos Rep; 2015 Oct; 13(5):274-9. PubMed ID: 26223903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.